Liposomes provide an established basis for the sustainable development of different
commercial products for treatment of medical diseases by the smart delivery of drugs. The …

Liposomes are the most widely used nanocarrier systems in medicine. Common strategies
for tumor-specific drug delivery using liposomes include the passive accumulation of …

Nanomedicine, particularly liposomal drug delivery, has expanded considerably over the
past few decades, and several liposomal drugs are already providing improved clinical …

Strategies used to enhance liposome-mediated drug delivery in vivo include the
enhancement of stability and circulation time in the bloodstream, targeting to specific tissues …

In the development of cancer chemotherapy, besides the discovery of new anticancer drugs,
a variety of nanocarrier systems for the delivery of previously developed and new …

Nanotechnology has started a new era in engineering multifunctional nanoparticles for
diagnosis and therapeutics by incorporating therapeutic drugs, targeting ligands, stimuli …

The delivery of chemotherapeutics to solid tumors using smart drug delivery systems
(SDDSs) takes advantage of the unique physiology of tumors (ie, disordered structure, leaky …

Liposomal technology has been widely used in the pharmaceutical field for the preparation
of nano-sized drug delivery systems based on natural or synthetic lipids. Liposomes …

Currently used pharmaceutical nanocarriers, such as liposomes, micelles, nanoemulsions,
polymeric nanoparticles and many others demonstrate a broad variety of useful properties …

Liposomes are being increasingly utilized to deliver drugs, enzymes, antisense
oligonucleotides, and genes to various therapeutic targets. Liposome-mediated delivery of …